Daily Archives: Oct 5, 2025
ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with...
Data from the first two cohorts demonstrated that combination of iadademstat plus gilteritinib was safe and showed strong antileukemic activityA third cohort is ongoing following FDA’s OPTIMUS guidance MADRID and CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a...
Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among...
THE WOODLANDS, Texas, June 14, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that three poster presentations will be delivered during the 84th Scientific Sessions of the American Diabetes Association being held June 21 - 24, 2024 at the Orange County Convention Center in Orlando,...
SLB and Aker Carbon Capture announce closing of carbon capture joint...
OSLO, Norway, June 14, 2024 /PRNewswire/ -- Aker Horizons ASA's portfolio company Aker Carbon Capture ASA ("ACC") announced today the final closing of their previously announced joint venture with SLB. The new company combines technology portfolios, expertise and operations platforms to support accelerated carbon capture adoption for industrial decarbonization...